Old Web
English
Sign In
Acemap
>
authorDetail
>
K. Kato
K. Kato
AbbVie
Medicine
Rheumatology
Adalimumab
Psoriatic arthritis
Placebo
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study.
2021
RMD Open
Iain B. McInnes
K. Kato
Marina Magrey
Joseph F. Merola
Mitsumasa Kishimoto
César Pacheco-Tena
Derek Haaland
Liang Chen
Yuanyuan Duan
Patrick Zueger
John Liu
R Lippe
Aileen L. Pangan
Franck Behrens
Show All
Source
Cite
Save
Citations (0)
Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1
2021
Vibeke Strand
Philip J. Mease
Enrique R. Soriano
Mitsumasa Kishimoto
Carlo Salvarani
Christopher D Saffore
Patrick Zueger
E. Mcdearmon-Blondell
K. Kato
Dafna D. Gladman
Show All
Source
Cite
Save
Citations (1)
1